EpiCast Report: Sepsis and Septic Shock - Epidemiology Forecast to 2026


#1306897

61pages

GlobalData

$ 3995

In Stock

EpiCast Report: Sepsis and Septic Shock - Epidemiology Forecast to 2026

Summary

Sepsis is a life-threatening complication arising from an infection, which occurs when the bodys response to the infection damages its own tissues and organs. Sepsis can lead to multiple organ failure and death, especially if it is not recognized early and treated promptly. Anyone can develop sepsis; however, the condition is more common among children less than one year of age, older adults, and those with weakened immune systems. Although any type of infection (bacterial, viral, or fungal) can lead to sepsis, people suffering from pneumonia, abdominal infection, kidney infection, and bloodstream infection (bacteremia) are more likely to develop sepsis. The most common pathogens for sepsis include bacteria (gram-positive, gram-negative), fungi, viruses, and parasites.

To forecast the diagnosed incident cases of sepsis and septic shock in the 7MM, GlobalData epidemiologists selected nationally representative population-based studies that provided diagnosed incidence and/or mortality rate of sepsis and septic shock in the 7MM. Additionally, the diagnostic criteria for sepsis and septic shock are based on the sepsis-3 definition across all 7MM in this analysis.

GlobalData epidemiologists forecast that the diagnosed incident cases of sepsis in the 7MM will grow at an Annual Growth Rate (AGR) of 2.06% per year over the next 10 years, from 2,594,665 cases in 2016 to 3,129,753 cases in 2026. GlobalData epidemiologists forecast that the diagnosed incident cases of septic shock in the 7MM will grow by an AGR of 2.07% per year over the next 10 years, from 539,085 cases in 2016 to 650,426 cases in 2026. The US will have the highest incident cases of sepsis and septic shock in the 7MM throughout the forecast period, while Japan had the lowest.

Scope

- The Sepsis and Septic Shock EpiCast Report provides an overview of the risk factors and global trends of sepsis and septic shock in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident cases of sepsis and septic shock, segmented by age (for all ages) and sex. The sepsis and septic shock diagnosed incident cases are further segmented by causative agent and organ dysfunction. Additionally, GlobalData epidemiologists provide a forecast for the in-hospital mortality cases of sepsis and septic shock, segmented by age for both sexes.
- The sepsis and septic shock epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
- The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy

The Sepsis and Septic Shock EpiCast report will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global sepsis and septic shock market.
- Quantify patient populations in the global sepsis and septic shock market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for sepsis and septic shock therapeutics in each of the markets covered.
- Understand the causative agent, organ dysfunction, and mortality of sepsis and septic shock.